News

By Brian Dolan January 13, 2010
Scottsdale, Arizona - January 14, 2010 - MedApps, Inc., a leading mHealth (mobile / remote health monitoring) company, announced today that it will partner with Meridian Health, a leading comprehensive healthcare provider in New Jersey, to initiate a chronic disease management pilot focused on patients discharged from acute care settings with Congestive Heart Failure (CHF). The focus of the...
By Brian Dolan January 13, 2010
Wireless continues wireline cannibalization: According to report from the CDC, preliminary results from the January-June 2009 National Health Interview Survey (NHIS) indicate that the number of American homes that only use mobile phones (no landlines) continues to increase. Some 22.7 percent of U.S. homes only used mobile phones during the first six months of 2009. That marks an increase of 2.5...
By Brian Dolan January 13, 2010
By Laurie Orlov, Founder, Aging in Place Technology Watch How CES is it? So by today, the press folks at the Consumer Electronics Show must have quite the headache from the racket and flashing displays. The Las Vegas onslaught of new electronics has been described in the NY TImes as a 'Deluge of Devices for Reading and Surfing', but I like Engadget's more playful term -- 'crapgadget' for...
By Brian Dolan January 13, 2010
The FDA recently approved MediSens Wireless' wireless body monitoring system, which assesses muscle and neuromotor functions in the upper extremities, for its first phase of clinical trials. MediSens' Clinical Movement Assessment System (CMAS) could be used by health care professionals working in physical medicine and rehabilitation, neurology, orthopedics and physical and occupational therapy....
By Brian Dolan January 13, 2010
After three months of rumors, details surrounding Epic Systems' partnership with Apple for a mobile phone-based electronic health record (EHR) application have come to light: Just a few days ago, Epic System's iPhone application, called Haiku, became available on Apple's AppStore. "Haiku provides authorized clinical users of Epic's Electronic Health Record with secure access to clinic schedules,...
By Brian Dolan January 12, 2010
Anthem Blue Cross, the trade name for Blue Cross of California, announced plans last week to work with wireless health company Ideal Life on a pilot program for congestive heart failure (CHF) patients called CARE (Congestive Heart Failure Ambulatory Remote monitoring and Engagement). Ideal Life is providing its wireless body weight scales for in-home use in an effort to leverage remote monitoring...
By Brian Dolan January 12, 2010
Anthem Blue Cross announced today that it has contracted with IDEAL LIFE® to provide wireless body weight scales for in-home use with Congestive heart Failure (CHF) patients. This initiative is the foundation of a new pilot program known as C.A.R.E. (Congestive Heart Failure Ambulatory Remote monitoring and Engagement). The program's goal is to utilize IDEAL LIFE's Bluetooth-enabled remote...
By Brian Dolan January 12, 2010
Last week we reported on Mayo Clinic's new mobile-focused startup: mRemedy, which is creating smartphone applications based on Mayo's medical research. mRemedy is a joint collaboration with application developer DoApps. The venture's first application was a meditation application that teaches users breathing exercises and other methods for reducing stress. According to a report from...
By Brian Dolan January 12, 2010
Pharmaceutical giant Novartis announced that would invest $24M in upfront cash and equity as part of an exclusive worldwide agreement for the pharma company to license Proteus Biomedical's sensing technology for organ transplantation. (That must be the kind of exclusive deal Novartis had in mind when the two companies announced their collaboration on a pilot last year.) As part of the deal,...
By Brian Dolan January 12, 2010
REDWOOD CITY, Calif. - Proteus Biomedical Inc., a pioneer in intelligent medicine, entered into an exclusive worldwide license and collaboration agreement with Novartis to develop and commercialize pharmaceutical products that incorporate Proteus’ novel sensor-based technologies in the field of organ transplantation. Novartis also receives certain option rights in cardiovascular and oncology...

Editor's Pick